Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    22840761 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Evaluation of the Initial Prescription of Ketamine and Milnacipran for Depression in Palliative Care
Condition: Depression
Interventions: Drug: Ketamine;   Drug: Milnacipran;   Drug: Placebo
2 Recruiting Ketamine Plus Lithium in Treatment-Resistant Depression
Condition: Depression
Interventions: Drug: Ketamine and Lithium;   Drug: Ketamine and Placebo
3 Completed Continuation Ketamine in Major Depression
Condition: Major Depressive Disorder
Interventions: Drug: Lithium;   Drug: Ketamine

Indicates status has not been verified in more than two years